2010China Modern MedicineRequires access

Efficacy of carvedilol in treatment of chronic heart failure

Liping Wang

Open publisher page 0 citations

Abstract

Objective:To evaluate the efficacy and safety of carvedilol in treatment of chronic heart failure (CHF). Meth-ods:90 patients with CHF were randomly divided into carvedilol group (45cases) and control group (45cases). Two groups were treated with the routine medicine,including digitalis,diuretics,ACEI and niteates.Carvedilol was added to carvedilol group. Carvedilol began from 5 mg per day and was gradually increased to 10-20 mg per day if they were tolerated. The treatment was lasted for 24 weeks.The heart function was evaluated once a week,and LVEF,LVEDD and LVESD were evaluated by echocardiography before and after treatment. Symptoms and signs were recorded. Results:After treatment,the heart function and LVEF significantly increased. LVEDD,LVESD in carvedilol group were reduced significantly. There was significantly difference between the two groups. Conclusion:Carvedilol is effective and safe in treating mild and moderate chronic congestive heart failure,which can improve the remodeling of left ventricle.

About this research paper

What this paper is about

Objective:To evaluate the efficacy and safety of carvedilol in treatment of chronic heart failure (CHF). Meth-ods:90 patients with CHF were randomly divided into carvedilol group (45cases) and control group (45cases). Two groups were treated with the routine medicine,including digitalis,diuretics,ACEI and niteates.Carvedilol was added to carvedilol group. Carvedilol began from 5 mg per day and was gradually increased to 10-20 mg per day if they were tolerated. The treatment was lasted for 24 weeks.The heart function was evaluated once a week,and LVEF,LVEDD and LVESD were evaluated by echocardiography before and after treatment. Symptoms and signs were recorded. Results:After treatment,the heart function and LVEF significantly increased. LVEDD,LVESD in carvedilol group were reduced significantly. There was significantly difference between the two groups. Conclusion:Carvedilol is effective and safe in treating mild and moderate chronic congestive heart failure,which can improve the remodeling of left ventricle.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the efficacy and safety of carvedilol in treatment of chronic heart failure (CHF). Meth-ods:90 patients with CHF were randomly divided into carvedilol group (45cases) and control group (45cases). Two groups were treated with the routine medicine,including digitalis,diuretics,ACEI and niteates.Carvedilol was added to carvedilol group. Carvedilol began from 5 mg per day and was gradually increased to 10-20 mg per day if they were tolerated. The treatment was lasted for 24 weeks.The heart function was evaluated once a week,and LVEF,LVEDD and LVESD were evaluated by echocardiography before and after treatment. Symptoms and signs were recorded. Results:After treatment,the heart function and LVEF significantly increased. LVEDD,LVESD in carvedilol group were reduced significantly. There was significantly difference between the two groups. Conclusion:Carvedilol is effective and safe in treating mild and moderate chronic congestive heart failure,which can improve the remodeling of left ventricle.

Key concepts: Carvedilol, Medicine, Heart failure, Ejection fraction, Digitalis, Ventricle, Internal medicine, Cardiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy of carvedilol in treatment of chronic heart failure — Research Paper | ScholarLens